DE000A3ENQ51
DE000A3ENQ51
SCHOTT Pharma AG & Co. KGaA I
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.54B EUR | 2.61B EUR | 2.04B EUR | 2.27B EUR |
Enterprise Value | 3.8B EUR | 2.58B EUR | 2.01B EUR | 2.25B EUR |
Valuation Multiples | ||||
Trailing P/E | 26.11x | 19.08x | 14.22x | 20.28x |
Forward P/E | 21.46x | -- | -- | -- |
Price to Sales | 3.48x | 2.56x | 2.05x | 3.06x |
Price to Book | 3.52x | 2.62x | 2.16x | 2.45x |
EV/Revenue | 3.73x | 2.54x | 2.03x | 3.02x |
EV/EBITDA | 15.22x | 9.21x | 6.98x | 10.16x |
Price to FCF (P/FCF) | -- | 47.31x | 34.66x | -- |
EV/FCF | -- | 46.85x | 34.18x | -- |
FCF Yield | -0.56% | 2.11% | 2.89% | -0.28% |